pSivida Corp. (NASDAQ:$PSDV) stock is currently on the up and up.
The stock finished Tuesday’s session 3.15% higher at $1.31, with a total trading volume of 570,811 shares. This means that the stock has risen 11.97% over the past three months. Furthermore, pSivida shares are actually trading above their 50-day moving average by 6.87%. Their Relative Strength Index (RSI) is sitting at 57.93.
A Buy rating has been initiated for pSivida stock by the research firm Laidlaw, setting a target price of $5 per share.
pSivida develops sustained-released drug-delivery products that are aimed at treating chronic eye diseases.
Featured Image: twitter
